Taurocholic acid metabolism by gut microbes and colon cancer

Gut Microbes

Volumn 7, Issue 3, 2016, Pages 201-215

  Ridlon, Jason M ^a   Wolf, Patricia G ^a   Gaskins, H Rex ^a,b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Bile acid; Colon cancer; Deoxycholic acid; Diet; Hydrogen sulfide; Taurine

Indexed keywords

DEOXYCHOLIC ACID; HYDROGEN SULFIDE; HYDROXYSTEROID DEHYDROGENASE; LITHOCHOLIC ACID; TAURINE; TAUROCHOLIC ACID; CHOLAGOGUE; DETERGENT; MUTAGENIC AGENT;

BACTERIAL METABOLISM; BACTEROIDES FRAGILIS; BILOPHILA WADSWORTHIA; CANCER MORTALITY; CLOSTRIDIUM PASTEURIANUM; COLON CANCER; DESULFOVIBRIONACEAE; ENTEROHEPATIC CIRCULATION; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; GENOTOXICITY; HUMAN; LIPID METABOLISM; MICROBIAL RESPIRATION; NONHUMAN; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; WESTERN DIET; BILE; COLON TUMOR; GASTROINTESTINAL TRACT; INTESTINE FLORA; METABOLISM; MICROBIOLOGY; SECRETION (PROCESS);

BILE; CHOLAGOGUES AND CHOLERETICS; COLONIC NEOPLASMS; DEOXYCHOLIC ACID; DETERGENTS; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; HUMANS; HYDROGEN SULFIDE; MUTAGENS; TAUROCHOLIC ACID;

EID: 84971663989     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2016.1150414     Document Type: Review

References (128)

1. N.Howlader, A.M.Noone, M.Krapcho, J.Garshell, D.Miller, S.F.Altekruse, C.L.Kosary, M.Yu, J.Ruhl, Z.Tatalovich, A.Mariotto, D.R.Lewis, H.S.Chen, E.J.Feuer, K.A.Cronin (eds). SEER Cancer Statistics Review, 1975–2012, National Cancer Institute. Bethesda, MD, http:// seer.cancer. gov/csr/1975_2012/,-based-on-November-2014-SEER-data-submission,-posted-to-the-SEER -web-site, April 2015.
2. J.A.O'Shaughnessy, G.J.Kelloff, G.B.Gordon, A.J.Dannenberg, W.K.Hong, C.J.Fabian, C.C.Sigman, M.M.Bertagnolli, S.P.Stratton, S.Lam, etal. Treatment and prevention of intraepithelial neoplasia: An important target for accelerated new agent development. Clin Cancer Res 2002; 8:314-46.
3. L.Durko, E.Malecka-Panas. Lifestyle modifications and colorectal cancer. Curr Colorectal Cancer Re 2014; 10:45-54; PMID:24659930; http://dx.doi.org/10.1007/s11888-013-0203-4
4. L.Biedermann, J.Zeitz, J.Mwinyi, E.Sutter-Minder, A.Rehman, S.J.Ott, C.Steurer-Stey, A.Frei, P.Frei, M.Scharl, etal. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013; 8(3):e59260; PMID:23516617; http://dx.doi.org/10.1371/journal.pone.0059260
5. E.A.Mutlu, P.M.Gillevet, H.Rangwala, M.Sikaroodi, A.Naqvi, P.A.Engen, M.Kwasny, C.K.Lau, A.Keshavarzian. Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol 2012; 302(9):G966-78; PMID:22241860; http://dx.doi.org/10.1152/ajpgi.00380.2011
6. Z.Gao, B.Guo, R.Gao, Q.Zhu, H.Qin. Microbiota dysbiosis is associated with colorectal cancer. Front Microbiol 2015; 6:20; PMID:25699023
7. C.M.Dejea, E.C.Wick, E.M.Hechenbleikner, J.R.White, J.L.Mark Welch, B.J.Rossetti, S.N.Peterson, E.C.Snesrud, G.G.Borisy, M.Lazarev, etal. Microbiota organization is a distinct feature of proximal colorectal cancers. Proc Natl Acad Sci U S A 2014; 111(51):18321-6; PMID:25489084; http://dx.doi.org/10.1073/pnas.1406199111
8. H.Brim, S.Yooseph, E.G.Zoetendal, E.Lee, M.Torralbo, A.O.Laiyemo, B.Shokrani, K.Nelson, H.Ashktorab. Microbiome analysis of stool samples from African Americans with colon polyps. PLoS One 2013; 8(12):e81352; PMID:24376500; http://dx.doi.org/10.1371/journal.pone.0081352
9. J.P.Zackular, N.T.Baxter, K.D.Iverson, W.D.Sadler, J.F.Petrosino, G.Y.Chen, P.D.Schloss. The gut microbiome modulates colon tumorigenesis. MBio 2013; 4(6):e00692-13; PMID:24194538; http://dx.doi.org/10.1128/mBio.00692-13
10. T.L.Weir, D.K.Manter, A.M.Sheflin, B.A.Barnett, A.L.Heuberger, E.P.Ryan. Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One 2013; 8(8):e70803; PMID:23940645; http://dx.doi.org/10.1371/journal.pone.0070803
11. J.R.Marchesi, B.E.Dutilh, N.Hall, W.H.Peters, R.Roelofs, A.Boleij, H.Tjalsma. Towards the human colorectal cancer microbiome. PLoS One 2011; 6(5):e20447; PMID:21647227; http://dx.doi.org/10.1371/journal.pone.0020447
12. K.Mima, R.Nishihara, Z.R.Qian, Y.Cao, Y.Sukawa, J.A.Nowak, J.Yang, R.Dou, Y.Masugi, M.Song, etal. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis. Gut 2015; pii: gutjnl-2015-310101. http://dx.doi.org/10.1136/gutjnl-2015-310101
13. K.Mima, Y.Sukawa, R.Nishihara, Z.R.Qian, M.Yamauchi, K.Inamura, S.A.Kim, A.Masuda, J.A.Nowak, K.Nosho, etal. Fusobacterium nucleatum and T cells in colorectal carcinoma. JAMA Oncol 2015; 1(5):653-61; PMID:26181352; http://dx.doi.org/10.1001/jamaoncol.2015.1377
14. A.N.McCoy, F.Araújo-Pérez, A.Azcárate-Peril, J.J.Yeh, R.S.Sandler, T.O.Keku. Fusobacterium is associated with colorectal adenomas. PLoS One 2013; 8(1):e53653; PMID:23335968; http://dx.doi.org/10.1371/journal.pone.0053653
15. C.L.Sears, A.L.Geis, F.Housseau. Bacteroides fragilis subverts mucosal biology: From symbiont to colon carcinogenesis. J Clin Invest 2014; 124(10):4166-72; PMID:25105360; http://dx.doi.org/10.1172/JCI72334
16. A.Boleij, E.M.Hechenbleikner, A.C.Goodwin, R.Badani, E.M.Stein, M.G.Lazarev, B.Ellis, K.C.Carroll, E.Albesiano, E.C.Wick, E.A.Platz, D.M.Pardoll, C.L.Sears. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 2015; 60(2):208-15; PMID:25305284; http://dx.doi.org/10.1093/cid/ciu787
17. J.Raisch, E.Buc, M.Bonnet, P.Sauvanet, E.Vazeille, A.de Vallée, P.Déchelotte, C.Darcha, D.Pezet, R.Bonnet, etal. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World J Gastroenterol 2014; 20(21):6560-72; PMID:24914378; http://dx.doi.org/10.3748/wjg.v20.i21.6560
18. J.M.Ridlon, J.M.Alves, P.B.Hylemon, J.S.Bajaj. Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship. Gut Microbes 2013; 4(5):382-7; PMID:23851335; http://dx.doi.org/10.4161/gmic.25723
19. J.M.Ridlon, D.J.Kang, P.B.Hylemon, J.S.Bajaj. Bile acids and the gut microbiome. Curr Opin Gastroenterol 2014; 30(3):332-8; PMID:24625896; http://dx.doi.org/10.1097/MOG.0000000000000057
20. H.Zhou, P.B.Hylemon. Bile acids are nutrient signaling hormones. Steroids 2014; 86:62-8; PMID:24819989; http://dx.doi.org/10.1016/j.steroids.2014.04.016
21. I.H.Lambert, D.M.Kristensen, J.B.Holm, O.H.Mortensen. Physiological role of taurine-from organism to organelle. Acta Physiol 2015; 213:191-212; http://dx.doi.org/10.1111/apha.12365
22. C.J.Reissig, E.C.Strain, R.R.Griffiths. Caffeinated energy drinks-a growing problem. Drug Alcohol Depend 2009; 99:1-10; PMID:18809264; http://dx.doi.org/10.1016/j.drugalcdep.2008.08.001
23. J.Y.Chiang. Bile acids: Regulation of synthesis. J Lipid Res 2009; 50:1955-1966; PMID:19346330; http://dx.doi.org/10.1194/jlr.R900010-JLR200
24. D.Q.Wang, M.C.Carey. Therapeutic uses of animal biles in traditional Chinese medicine: An ethnopharmacological, biophysical chemical and medicinal review. World J Gastroenterol 2014; 20(29):9952-75; PMID:25110425; http://dx.doi.org/10.3748/wjg.v20.i29.9952
25. A.F.Hofmann, L.R.Hagey, M.D.Krasowski. Bile salts of vertebrates: Structural variation and possible evolutionary significance. J Lipid Res 2010; 51(2):226-46; PMID:19638645; http://dx.doi.org/10.1194/jlr.R000042
26. A.F.Hofmann, A.Roda. Physicochemical properties of bile acids and their relationship to biological properties: An overview of the problem. J Lipid Res 1984; 25:1477-89; PMID:6397555
27. P.G.Killenberg, J.T.Jordan. Purification and characterization of bile acid-CoA:amino acid N-acyltransferase from rat liver. J Biol Chem 1978; 253(4):1005-10; PMID:624713
28. T.Shersten. in Metabolic Conjugation and Metabolic Hydrolysis (W.H.Fisherman,, ed) 1971; pp. 75-121, Academic Press, New York.
29. D.A.Vessey. The co-purification and common identity of cholyl CoA:glycine- and cholyl CoA:taurine-N-acyltransferase activities from bovine liver. J Biol Chem 1979; 254(6):2059-63; PMID:422567
30. M.R.Johnson, S.Barnes, D.J.Sweeny, R.B.Diasio. 2-Fluoro-beta-alanine, a previously unrecognized substrate for bile acid coenzyme A:amino acid:N-acyltransferase from human liver. Biochem Pharmacol 1990; 40(6):1241-46; PMID:2119585; http://dx.doi.org/10.1016/0006-2952(90)90389-3
31. W.G.M.Hardison. Hepatic taurine concentration and dietary taurine as regulators of bile acid conjugation with taurine. Gastroenterology 1978; 75:71-75; PMID:401099
32. J.Sjöval. Dietary glycine and taurine on bile acid conjugation in man. Bile acids and steroids 75. Proc Soc Exp Biol Med 1959; 100(4):676-8; PMID:13645682; http://dx.doi.org/10.3181/00379727-100-24741
33. C.N.Falany, M.R.Johnson, S.Barnes, R.B.Diasio. Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA:amino acid N-acyltransferase. J Biol Chem 1994; 269(30):19375-9; PMID:8034703
34. A.F.Hofmann. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999; 159(22):2647-58; PMID:10597755; http://dx.doi.org/10.1001/archinte.159.22.2647
35. P.A.Dawson, S.J.Karpen. Intestinal transport and metabolism of bile acids. J Lipid Res 2015; 56(6):1085-99; PMID:25210150; http://dx.doi.org/10.1194/jlr.R054114
36. A.F.Hofmann, L.R.Hagey. Key discoveries in bile acid chemistry and biology and their clinical applications: History of the last eight decades. J Lipid Res 2014; 55:1553-1595; PMID:24838141; http://dx.doi.org/10.1194/jlr.R049437
37. J.M.Ridlon, S.C.Harris, S.Bhowmilk, D.Kang, P.B.Hylemon. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 2016; 7(1):22-39.
38. D.T.Hughes, V.Sperandio. Inter-kingdom signaling: Communication between bacteria and their hosts. Nat Rev Microbiol 2008; 6:111-120; PMID:18197168; http://dx.doi.org/10.1038/nrmicro1836
39. J.M.Ridlon, D.J.Kang, P.B.Hylemon. Bile salt biotransformations by human intestinal bacteria. J Lipid Res 2006; 47(2):241-59; PMID:16299351; http://dx.doi.org/10.1194/jlr.R500013-JLR200
40. A.K.Batta, G.Salen, R.Arora, S.Shefer, M.Batta, A.Person. Side chain conjugation prevents bacterial 7-dehydroxylation of bile acids. J Biol Chem 1990; 265(19):10925-28; PMID:2358447
41. E.J.Stellwag, P.B.Hylemon. 7alpha-dehydroxylation of cholic acid and chenodeoxycholic acid by Clostridium leptum. J Lipid Res 1979; 20(3):325-333; PMID:36438
42. A.S.Devlin, M.A.Fischbach. A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol 2015; 11(9):685-90; PMID:26192599; http://dx.doi.org/10.1038/nchembio.1864
43. I.A.Macdonald, B.A.White, P.B.Hylemon. Separation of 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activities from clostridium absonum ATCC# 27555 and cellular response of this organism to bile acid inducers. J Lipid Res 1983; 24(9):1119-26; PMID:6579144
44. M.Kitahara, F.Takamine, T.Imamura, Y.Benno. Assignment of Eubacterium sp. VPI 12708 and related strains with high bile acid 7alpha-dehydroxylating activity to Clostridium scindens and proposal of Clostridium hylemonae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2000; 50 Pt 3:971-8; PMID:10843034; http://dx.doi.org/10.1099/00207713-50-3-971
45. K.B.Islam, S.Fukiya, M.Hagio, N.Fujii, S.Ishizuka, T.Ooka, Y.Ogura, T.Hayashi, A.Yokota. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 2011; 141(5):1773-81; PMID:21839040; http://dx.doi.org/10.1053/j.gastro.2011.07.046
46. C.G.Buffie, V.Bucci, R.R.Stein, P.T.McKenney, L.Ling, A.Gobourne, D.No, H.Liu, M.Kinnebrew, A.Viale, etal. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 2015; 517(7533):205-8; PMID:25337874; http://dx.doi.org/10.1038/nature13828
47. L.A.David, C.F.Maurice, R.N.Carmody, D.B.Gootenberg, J.E.Button, B.E.Wolfe, A.V.Ling, A.S.Devlin, Y.Varma, M.A.Fischbach, etal. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505(7484):559-63; PMID:24336217; http://dx.doi.org/10.1038/nature12820
48. S.J.O'Keefe, J.V.Li, L.Lahti, J.Ou, F.Carbonero, K.Mohammed, J.M.Posma, J.Kinross, E.Wahl, E.Ruder, etal. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun 2015; 6:6342; PMID:25919227; http://dx.doi.org/10.1038/ncomms7342
49. M.Makishima, T.T.Lu, W.Xie, G.K.Whitfield, H.Domoto, R.M.Evans, M.R.Haussler, D.J.Mangelsdorf. Vitamin D receptor as an intestinal bile acid sensor. Science 2002; 296(5571):1313-6; PMID:12016314; http://dx.doi.org/10.1126/science.1070477
50. D.M.Heuman. Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 1989; 30(5):719-30; PMID:2760545
51. E.A.Magee, C.J.Richardson, R.Hughes, J.H.Cummings. Contribution of dietary protein to sulfide production in the large intestine: An in vitro and a controlled feeding study in humans. Am J Clin Nutr 2000; 72(6):1488-94; PMID:11101476
52. S.Devkota, Y.Wang, M.W.Musch, V.Leone, H.Fehlner-Peach, A.Nadimpalli, D.A.Antonopoulos, B.Jabri, E.B.Chang. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10−/− mice. Nature 2012; 487(7405):104-8; PMID:22722865
53. S.Finegold, P.Summanen, S.H.Gerardo, E.Baron. (1992) Clinical importance of Bilophila wadsworthia. Eur J Clin Microbiol Infect Dis 1992; 11:1058-63; PMID:1295759; http://dx.doi.org/10.1007/BF01967799
54. M.C.Claros, U.K.Schumacher, M.Jacob, S.Hunt Gerardo, N.Kleinkauf, E.J.C.Goldstein, S.M.Finegold, A.C.Rodloff. Characterization ofBilophila wadsworthia isolates using PCR fingerprinting. Anaerobe 1999; 5:589-593; http://dx.doi.org/10.1006/anae.1999.0307
55. J.Loubinoux, F.Mory, I.A.Pereira, A.E.Le Faou. Bacteremia caused by a strain of Desulfovibrio related to the provisionally named Desulfovibrio fairfieldensis. J Clin Microbiol 2000; 38(2):931-4; PMID:10655421
56. W.Tee, M.Dyall-Smith, W.Woods, D.Eisen. Probable new species of Desulfovibrio isolated from a pyogenic liver abscess. J Clin Microbiol 1996; 34(7):1760-64; PMID:8784584
57. J.Lengeler, G.Drews, H.Schlegel. Biology of the Prokaryotes 1999. Pp. 293. Wiley-Blackwell.
58. A.L.Müller, K.U.Kjeldsen, T.Rattei, M.Pester, A.Loy. Phylogenetic and environmental diversity of DsrAB-type dissimilatory (bi)sulfite reductases. The ISME Journal 2014; 9:1152-1165; PMID:25343514; http://dx.doi.org/10.1038/ismej.2014.208
59. C.J.Huang, E.L.Barrett. Sequence analysis and expression of the Salmonella typhimurium asr operon encoding production of hydrogen sulfide from sulfite. J Bacteriol 1991; 173(4):1544-53; PMID:1704886
60. G.Harrison, C.Curle, E.J.Laishley. Purification and characterization of an inducible dissimilatory type sulfite reductase from Clostridium pasteurianum. Arch Microbiol 1984; 138(1):72-8; PMID:6742957; http://dx.doi.org/10.1007/BF00425411
61. H.Laue, M.Friedrich, J.Ruff, A.M.Cook. Dissimilatory sulfite reductase (desulfoviridin) of the taurine-degrading, non-sulfate-reducing bacterium Bilophila wadsworthia RZATAU contains a fused DsrB-DsrD subunit. J Bacteriol 2001; 183(5):1727-33; PMID:11160104; http://dx.doi.org/10.1128/JB.183.5.1727-1733.2001
62. G.M.Nava, F.Carbonero, J.A.Croix, E.Greenberg, H.R.Gaskins. Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. ISME J 2012; 6(1):57-70; PMID:21753800; http://dx.doi.org/10.1038/ismej.2011.90
63. E.L.Wynder. The epidemiology of large bowel cancer. Cancer Res 1975; 35(11 Pt.2):3388-94; PMID:1192406
64. E.L.Wynder, T.Kajitani, S.Ishikawa, H.Dodo, A.Takano. Environmental factors of cancer of the colon and rectum. II. Japanese epidemiological data. Cancer 1969; 23(5):1210-20; PMID:5778239; http://dx.doi.org/10.1002/1097-0142(196905)23:5%3c1210::AID-CNCR2820230530%3e3.0.CO;2-M
65. W.Haenszel, J.W.Berg, M.Segi, M.Kurihara, F.B.Locke. Large-bowel cancer in Hawaiian Japanese. J Natl Cancer Inst 1973; 51(6):1765-79; PMID:4797262
66. E.WYNDEREL, F.LEMONFR, I.BROSSIJ. Cancer and coronary artery disease among Seventh-Day Adventists. Cancer 1959; 12:1016-28; PMID:13846288; http://dx.doi.org/10.1002/1097-0142(195909/10)12:5%3c1016::AID-CNCR2820120523%3e3.0.CO;2-2
67. E.L.Wynder, T.Shigematsu. Environmental factors of cancer of the colon and rectum. Cancer 1967; 20(9):1520-61; PMID:6038396; http://dx.doi.org/10.1002/1097-0142(196709)20:9%3c1520::AID-CNCR2820200920%3e3.0.CO;2-3
68. B.S.Reddy, E.L.Wynder. Large-bowel carcinogenesis: Fecal constituents of populations with diverse incidence rates of colon cancer. J Natl Cancer Inst 1973; 50(6):1437-42; PMID:4717561
69. B.S.Reddy, A.Mastromarino, E.L.Wynder. Further leads on metabolic epidemiology of large bowel cancer. Cancer Res 1975; 35(11 Pt. 2):3403-6; PMID:1104152
70. B.S.Reddy, E.L.Wynder. Metabolic epidemiology of colon cancer. Fecal bile acids and neutral sterols in colon cancer patients and patients with adenomatous polyps. Cancer 1977; 39(6):2533-9; PMID:872053; http://dx.doi.org/10.1002/1097-0142(197706)39:6%3c2533::AID-CNCR2820390634%3e3.0.CO;2-X
71. E.L.Wynder, B.S.Reddy. Diet and cancer of the colon. Curr Concepts Nutr 1977; 6:55-71; PMID:604018
72. B.S.Reddy, J.H.Weisburger, E.L.Wynder. Fecal bacterial beta-glucuronidase: Control by diet. Science 1974; 183(4123):416-7; PMID:4808971; http://dx.doi.org/10.1126/science.183.4123.416
73. S.J.O'Keefe, M.Kidd, G.Espitalier-Noel, P.Owira. Rarity of colon cancer in Africans is associated with low animal product consumption, not fiber. Am J Gastroenterol 1999; 94(5):1373-80; PMID:10235221; http://dx.doi.org/10.1111/j.1572-0241.1999.01089.x
74. S.Sharma, S.J.O'Keefe. Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J 2007; 83(983):583-89; PMID:17823224; http://dx.doi.org/10.1136/pgmj.2007.058958
75. A.Berg. Nutrition, development and population growth. Popul Bull 1973; 29:3-37; PMID:12309299
76. L.Le Marchand, L.N.Kolonel. Cancer in Japanese migrants to Hawaii: Interaction between genes and environment. Rev Epidemiol Sante Publique 1992; 40(6):425-30; PMID:1287741
77. D.P.Burkitt. Epidemiology of cancer of the colon and the rectum. Cancer 1971; 28(1):3-13; PMID:5165022; http://dx.doi.org/10.1002/1097-0142(197107)28:1%3c3::AID-CNCR2820280104%3e3.0.CO;2-N
78. J.Ou, F.Carbonero, E.G.Zoetendal, J.P.DeLany, M.Wang, K.Newton, H.R.Gaskins, S.J.O'Keefe. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr 2013; 98(1):111-20; PMID:23719549; http://dx.doi.org/10.3945/ajcn.112.056689
79. T.Narisawa, N.E.Magadia, J.H.Weisburger, E.L.Wynder. Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst 1974; 53(4):1093-7; PMID:4427390
80. B.S.Reddy, T.Narasawa, J.H.Weisburger, E.L.Wynder. Promoting effect of sodium deoxycholate on colon adenocarcinomas in germfree rats. J Natl Cancer Inst 1976; 56(2):441-2; PMID:1255778
81. B.S.Reddy, K.Watanabe, J.H.Weisburger, E.L.Wynder. Promoting effect of bile acids in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res 1977; 37(9):3238-42; PMID:884672
82. B.S.Reddy, J.H.Weisburger, E.L.Wynder. Effects of dietary fat level and dimethylhydrazine on fecal acid and neutral sterol excretion and colon carcinogenesis in rats. J Natl Cancer Inst 1974; 52(2):507-11; PMID:4816006
83. A.van Faassen, T.Ochsenkühn, S.Houterman, E.M.van der Ploeg, B.H.Bueno-de-Mesquita, M.C.Ocké, E.Bayerdörffer, R.A.Janknegt. Plasma deoxycholic acid is related to deoxycholic acid in faecal water. Cancer Lett 1977; 114(1-2):293-294; http://dx.doi.org/10.1016/S0304-3835(97)04683-1
84. E.Bayerdörffer, G.A.Mannes, T.Ochsenkühn, P.Dirschedl, B.Wiebecke, G.Paumgartner. Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 1995; 36(2):268-73; PMID:7883228; http://dx.doi.org/10.1136/gut.36.2.268
85. E.Bayerdörffer, G.A.Mannes, W.O.Richter, T.Ochsenkühn, B.Wiebecke, W.Köpcke, G.Paumgartner. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology 1993; 104(1):145-151; PMID:8419237
86. T.Ochsenkühn, E.Bayerdörffer, A.Meining, M.Schinkel, C.Thiede, V.Nüssler, M.Sackmann, R.Hatz, A.Neubauer, G.Paumgartner. Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 1999; 85(8):1664-1669; PMID:10223558; http://dx.doi.org/10.1002/(SICI)1097-0142(19990415)85:8%3c1664::AID-CNCR4%3e3.0.CO;2-O
87. K.Cheng, J.P.Raufman. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors. Biochem Pharmacol 2005; 70(7):1035-1047; PMID:16139803; http://dx.doi.org/10.1016/j.bcp.2005.07.023
88. J.R.Brown, R.N.DuBois. COX-2: A molecular target for colorectal cancer prevention. J Clin Oncol 2005; 23:2840-2855; PMID:15837998; http://dx.doi.org/10.1200/JCO.2005.09.051
89. L.Qiao, E.Studer, K.Leach, R.McKinstry, S.Gupta, R.Decker, R.Kukreja, K.Valerie, P.Nagarkatti, W.El Deiry, etal. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: Inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol Biol Cell 2001; 12(9):2629-2645; PMID:11553704; http://dx.doi.org/10.1091/mbc.12.9.2629
90. R.Pai, A.S.Tarnawski, T.Tran. Deoxycholic acid activates β-catenin signaling pathway and increases colon cell cancer growth and invasiveness. Mol Biol Cell 2004; 15:2156-2163; PMID:15004225; http://dx.doi.org/10.1091/mbc.E03-12-0894
91. S.Munemitsu, I.Albert, B.Souza, B.Rubinfeld, P.Polakis. Regulation of intracellular betacatenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1995; 92(7):3046-3050; PMID:7708772; http://dx.doi.org/10.1073/pnas.92.7.3046
92. M.Oshima, H.Oshima, K.Kitagawa, M.Kobayashi, C.Itakura, M.Taketo. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apcgene. Proc Natl Acad Sci USA 1995; 92:4482-4486; PMID:7753829; http://dx.doi.org/10.1073/pnas.92.10.4482
93. H.K.Lee, S.Jeong. β-catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3′-UTR. Nucl Acids Res 2006; 34(19):5705-5714; PMID:17040897; http://dx.doi.org/10.1093/nar/gkl698
94. D.Qiao, S.V.Gaitonde, W.Qi, J.D.Martinez. Deoxycholic acid suppresses p53 by stimulating proteosome-mediated p53 protein degradation. Carcinogenesis 2001; 22(6):957-964; PMID:11375905; http://dx.doi.org/10.1093/carcin/22.6.957
95. S.U.Christl, W.Scheppach, H.Kasper. Hydrogen metabolism in the large intestine-physiology and clinical implications. Z Gastroenterol 1995; 33:408-13; PMID:7571760
96. M.C.L.Pitcher, E.R.Beatty, J.H.Cummings. The contribution of sulphate reducing bacteria and 5-aminosalicyclic acid to fecal sulphide in patients with ulcerative colitis. Gut 2000; 46:64-72; PMID:10601057; http://dx.doi.org/10.1136/gut.46.1.64
97. G.R.Gibson, J.H.Cummings, G.T.Macfarlane. Growth and activities of sulphate reducing bacteria in gut contents of healthy subjects and patients with ulcerative colitis. FEMS Microbiol Ecol 1991; 86:101-112; http://dx.doi.org/10.1111/j.1574-6968.1991.tb04799.x
98. W.E.Roediger, J.Moore, W.Babidge. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 1997; 42:1571-1579; PMID:9286219; http://dx.doi.org/10.1023/A:1018851723920
99. J.Moore, W.Babidge, S.Millard, W.E.Roediger. Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis. Dig Dis Sci 1998; 43:162-65; PMID:9508519; http://dx.doi.org/10.1023/A:1018848709769
100. W.E.Roediger. The colonic epithelium in ulcerative colitis: An energy deficiency disease? Lancet 1980; 2:712-715; PMID:6106826; http://dx.doi.org/10.1016/S0140-6736(80)91934-0
101. W.E.Roediger, S.Nance. Metabolic induction of experimental colitis by inhibition of fatty acid oxidation. Br J Exp Pathol 1986; 67:773-82; PMID:3099821
102. W.Babidge, S.Millard, W.E.Roediger. Sulfides impair short chain fatty acid beta-oxidation at acyl-CoA dehydrogenase level in colonocytes: Implications for ulcerative colitis. Mol Cell Biochem 1998; 181:117-124; PMID:9562248; http://dx.doi.org/10.1023/A:1006838231432
103. W.E.Roedinger, M.J.Lawson, V.Kwok, A.Kerr Grant, P.R.Pannall. Colonic bicarbonate output as a test of disease activity in ulcerative colitis. J Clin Pathol 1984; 37:704-7; PMID:6327778; http://dx.doi.org/10.1136/jcp.37.6.704
104. E.Den Hond, E.Hiele, Y.Ghoos, P.Rutgeerts. In vivo colonic butyrate metabolism in extensive ulcerative colitis. Gastroenterology 1998; 115(3):584-90; PMID:9721155; http://dx.doi.org/10.1016/S0016-5085(98)70137-4
105. M.D.Levitt, J.Springfield, J.Furne, T.Koenig, F.Suarez. Physiology of sulfide in the rat colon: Use of bismuth to assess colonic sulfide production. J Appl Physiol 2002; 92:L1655-60; http://dx.doi.org/10.1152/japplphysiol.00907.2001
106. S.U.Christl, H.D.Eisner, G.Dusel, H.Kasper, W.Sheppach. Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: A potential role for these agents in the pathogenesis of ulcerative colitis. Dig Dis Sci 1996; 41:2477-81; PMID:9011461; http://dx.doi.org/10.1007/BF02100146
107. J.M.Harig, K.H.Soergel, R.A.Komorowski, C.M.Wood. Treatment of diversion colitis with short chain fatty acid irrigation. N Engl J Med 1989; 320:23-6; PMID:2909876; http://dx.doi.org/10.1056/NEJM198901053200105
108. W.Sheppach, H.Sommer, T.Kirchner, G.M.Paganelli, P.Bartram, S.Christl, F.Richter, G.Dusel, H.Kasper. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992; 103:51-56; PMID:1612357
109. L.Shaw, P.C.Engel. CoA-persulphide: A possible in vivo inhibitor of mammalian short-chain acyl-CoA dehydrogenase. Biochim Biophys Acta 1987; 919(2):171-4; PMID:3580384; http://dx.doi.org/10.1016/0005-2760(87)90204-9
110. K.Wilson, M.Mudra, J.Furne, M.Levitt. Differentiation of the roles of sulfide oxidase and rhodanese in the detoxification of sulfide by the colonic mucosa. Dig Dis Sci 2008; 53:277-283; PMID:17551834; http://dx.doi.org/10.1007/s10620-007-9854-9
111. U.Theissen, M.Hoffmeister, M.Grieshaber, W.Martin. Single eubacterial origin of eukaryotic sulfide:quinone oxidoreductase, a mitochondrial enzyme conserved from the early evolution of eukaryotes during anoxic and sulfidic times. Mol Biol Evol 2003; 20:1564-74; PMID:12832624; http://dx.doi.org/10.1093/molbev/msg174
112. M.Gouben, M.Andriamihaja, T.Nübel, F.Blachier, F.Bouillaud. Sulfide, the first inorganic substrate for human cells. FASEB J 2007; 21:1699-1706; PMID:17314140; http://dx.doi.org/10.1096/fj.06-7407com
113. S.Ramasamy, S.Singh, P.Taniere, M.J.S.Langman, M.C.Eggo. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Physiol Gastrointest Liver Physiol 2006; 291:G288-G296; PMID:16500920; http://dx.doi.org/10.1152/ajpgi.00324.2005
114. S.Toden, A.R.Bird, D.L.Topping,, M.A.Conlon. Resistant starch prevents colonic DNA damage induced by high dietary cooked red meat or casein in rats. Cancer Biol Ther 2006; 5:267-72; PMID:16410726; http://dx.doi.org/10.4161/cbt.5.3.2382
115. S.Toden, A.R.Bird, D.L.Topping, M.A.Conlon. High red meat diets induce greater numbers of colonic DNA double-strand breaks than white meat in rats: Attenuation by high-amylose maize starch. Carcinogenesis 2007; 28:2355-62; PMID:17916911; http://dx.doi.org/10.1093/carcin/bgm216
116. K.Kanazawa, F.Konishi, T.Mitsuoka, A.Terada, K.Itoh, S.Narushima, M.Kumemura, H.Kimura. Factors influencing the development of sigmoid colon cancer. Bacteriologic and biochemical studies. Cancer 1996; 77(8 Suppl):1701-6; PMID:8608565; http://dx.doi.org/10.1002/(SICI)1097-0142(19960415)77:8+%3c1701::AID-CNCR18%3e3.0.CO;2-1
117. M.Yamada, T.Ohkusa, I.Okayasu. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 1992; 33(11):1521-27; PMID:1333439; http://dx.doi.org/10.1136/gut.33.11.1521
118. M.Castellarin, R.L.Warren, J.D.Freeman, L.Dreolini, M.Krzywinski, J.Strauss, R.Barnes, P.Watson, E.Allen-Vercoe, R.A.Moore, etal. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012; 22:299-306; PMID:22009989; http://dx.doi.org/10.1101/gr.126516.111
119. A.D.Kostic, E.Chun, L.Robertson, J.N.Glickman, C.A.Gallini, M.Michaud, T.E.Clancy, D.C.Chung, P.Lochhead, G.L.Hold, etal. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013; 14:207-15; PMID:23954159; http://dx.doi.org/10.1016/j.chom.2013.07.007
120. B.Deplancke, H.R.Gaskins. Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells. FASEB J 2003; 17:1310-12; PMID:12738807
121. M.S.Attene-Ramos, G.M.Nava, M.G.Muellner, E.D.Wagner, M.J.Plewa, H.R.Gaskins. DNA damage and toxicogenomic analyses of hydrogen sulfide in human intestinal epithelial FHs 74 Int cells. Environ Mol Mutagen 2010; 51:304-14; PMID:20120018
122. M.S.Attene-Ramos, E.D.Wagner, M.J.Plewa, H.R.Gaskins. Evidence that hydrogen sulfide is a genotoxic agent. Mol Cancer Res 2006; 4:9-14; PMID:16446402; http://dx.doi.org/10.1158/1541-7786.MCR-05-0126
123. M.S.Attene-Ramos, E.D.Wagner, H.R.Gaskins, M.J.Plewa. Hydrogen sulfide induces direct radical-associated DNA damage. Mol Cancer Res 2007; 5(5):455-59; PMID:17475672; http://dx.doi.org/10.1158/1541-7786.MCR-06-0439
124. J.Van Eldere, P.Celis, G.De Pauw, E.Lesaffre, H.Eyssen. Tauroconjugation of cholic acid stimulates 7alpha-dehydroxylation by fecal bacteria. Appl Environ Microbiol 1996; 62(2):656-61; PMID:8593067
125. S.Narushima, K.Itoha, Y.Miyamoto, S.H.Park, K.Nagata, K.Kuruma, K.Uchida. Deoxycholic acid formation in gnotobiotic mice associated with human intestinal bacteria. Lipids 2006; 41(9):835-43; PMID:17152920; http://dx.doi.org/10.1007/s11745-006-5038-1
126. L.K.Stenman, R.Holma, R.Forsgård, H.Gylling, R.Korpela. Higher fecal bile acid hydrophobicity is associated with exacerbation of dextran sodium sulfate colitis in mice. J Nutr 2013; 143(11):1691-97; PMID:24047703; http://dx.doi.org/10.3945/jn.113.180810
127. S.Craciun, E.P.Balskus. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci USA 2012; 109(52):21307-12; PMID:23151509; http://dx.doi.org/10.1073/pnas.1215689109
128. Z.Wang, E.Klipfell, B.J.Bennett, R.Koeth, B.S.Levison, B.Dugar, A.E.Feldstein, E.B.Britt, X.Fu, Y.M.Chung, etal. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472(7341):57-63; PMID:21475195; http://dx.doi.org/10.1038/nature09922